Department of Pharmaceutical Chemistry

HIV 2020: Where are we now? The intersection of HIV research and community service

Wed Sep 16, 2020
QBI TV presents a live discussion on the future of the HIV/AIDS epidemic. Join our conversation with HIV researchers and activists on the barriers that exist between scientists and advocates in the HIV community, as well as the goals that still need to be met to address the disconnect between...

Class of ’23 joins ranks of pharmacy at White Coat Ceremony

Mon Sep 14, 2020
Guglielmo.

Dean B. Joseph Guglielmo, PharmD, greeted the class.

With the COVID-19 pandemic precluding in-person events, the ceremony took place remotely.

QBI/SBI Symposium on Molecular Networks of Cancer and Other Diseases

Thu Sep 10, 2020
This inaugural event is organized by Drs. Walter Kolch of the University College Dublin (UCD) and Nevan Krogan of the Quantitative Biosciences Institute at the University of California, San Francisco (UCSF).

Clustering of functional protein loop conformations: applications to kinases, antibodies, and Ras: a QBI online seminar with Roland Dunbrack

Wed Sep 9, 2020
Dunbrack.
The QBI Online Seminar Series presents Roland Dunbrack, researcher at the Institute for Cancer Research at the Fox Chase Cancer Center. Dr. Dunbrack obtained his PhD from Harvard University under the direction of Martin Karplus and Jack Strominger followed by postdoctoral work with Fred Cohen and...

Update from the Dean: Back to school

Thu Aug 13, 2020
Guglielmo

Dean B. Joseph Guglielmo, PharmD

Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

Wed Aug 12, 2020
Aerosol spray
Noah Berger

The antiviral invented by Aashish Manglik, PhD, and colleagues is effective at blocking SARS-CoV-2 infection even as an aerosolized spray, according to laboratory testing.

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

QCRG and Subgroups Town Hall

Tue Aug 4, 2020
The evolving COVID-19 situation is prompting quick responses from within our local research community and labs. In order to keep UCSF researchers informed of changes to the research activities as well as current research related to COVID-19, the Quantitative Biosciences Institute (QBI) at UCSF is...

How does Toxoplasma gondii initiate infection in a new host?: a QBI online seminar with Pascale Guiton

Tue Aug 4, 2020
Guiton.
The QBI Online Seminar Series presents Pascale Guiton, assistant professor of biological sciences at the California State University East Bay. Pascale trained as a molecular microbiologist at Washington University in St. Louis and at Stanford University School of Medicine. Her research focuses on...

Science in the Time of Corona: Could COVID-19 change the role of conferences in science?

Thu Jul 30, 2020
people in online meeting.
QBI presents Science in the Time of Corona, a live show where scientists discuss how COVID-19 has changed science. Join us for a discussion with two researchers in the QBI Coronavirus Research Group (QCRG) about the transition to online conferences that has been made necessary by COVID-19 and...

Dozens of presumed inactive ingredients may impact human biology

Wed Jul 29, 2020
Various pills
Morguefile.com

School scientists have found that various inactive ingredients in drugs, known as excipients, may produce unwanted side effects in the human body.

School scientists identify excipients with potential to cause side effects

Pages